Remove trial restrictions Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Colorcon
Moodys
Mallinckrodt
Harvard Business School

Last Updated: May 17, 2022

CLINICAL TRIALS PROFILE FOR ROSUVASTATIN CALCIUM


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Rosuvastatin Calcium

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00214630 ↗ LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes Completed AstraZeneca Phase 3 2003-12-01 Comparison of rosuvastatin and atorvastatin in subjects with acute coronary syndromes
NCT00225589 ↗ A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR) Completed AstraZeneca Phase 3 2002-08-01 The purpose of this trial is to see if rosuvastatin will be effective in decreasing the thickness of the walls of the arteries in the neck for people who already have some evidence of thickening of these walls.
NCT00240318 ↗ A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID) Completed AstraZeneca Phase 3 2002-11-01 The purpose of this study is to see if 40 mg of rosuvastatin taken daily will reduce the atherosclerosis (fatty deposits) in your arteries
NCT00295373 ↗ Exercise And Rosuvastatin Treatment: Is There an Anti-Inflammatory Synergy? Unknown status Purdue University Phase 4 2006-02-01 The purpose of this study is to determine whether the effects of rosuvastatin treatment and exercise training can be synergistic, with respect to the innate immune receptor TLR4, markers of systemic inflammation, and stimulated production of inflammatory cytokines, in hypercholesterolemic subjects. It is hypothesized that a rosuvastatin and exercise intervention will synergistically lower measured variables, so as to be anti-inflammatory.
NCT00300430 ↗ Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia. Completed Abbott Phase 3 2006-09-01 The primary purpose of this study is to test the safety and the effects of using an investigational drug regimen; once daily ABT-335 (Investigational drug) administered in combination with once daily atorvastatin calcium, rosuvastatin calcium or simvastatin in patients with abnormal lipid levels in the blood.
NCT00300482 ↗ Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood Completed Abbott Phase 3 2006-03-01 The purpose of this study is to compare the safety and efficacy of fenofibric acid (ABT-335) + rosuvastatin calcium combination therapy with ABT-335 and rosuvastatin calcium monotherapy in subjects with multiple abnormal lipid levels in the blood.
NCT00329160 ↗ Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease Completed Shionogi Phase 4 2005-10-01 The primary objective of this study is to evaluate that 76 weeks of treatment with rosuvastatin calcium 2.5-20 mg results in no progression of coronary artery atherosclerotic volume as measured by intravascular ultrasonography (IVUS) imaging in hypercholesterolaemic subjects with coronary heart disease (CHD).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Rosuvastatin Calcium

Condition Name

Condition Name for Rosuvastatin Calcium
Intervention Trials
Healthy 4
Dyslipidemia 4
Healthy Subjects 3
Mixed Dyslipidemia 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Rosuvastatin Calcium
Intervention Trials
Dyslipidemias 7
Hypercholesterolemia 6
Myocardial Ischemia 5
Coronary Artery Disease 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Rosuvastatin Calcium

Trials by Country

Trials by Country for Rosuvastatin Calcium
Location Trials
United States 101
Canada 9
Netherlands 4
Italy 4
Belgium 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Rosuvastatin Calcium
Location Trials
Illinois 7
Florida 7
Ohio 5
Wisconsin 4
Texas 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Rosuvastatin Calcium

Clinical Trial Phase

Clinical Trial Phase for Rosuvastatin Calcium
Clinical Trial Phase Trials
Phase 4 4
Phase 3 11
Phase 2 2
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Rosuvastatin Calcium
Clinical Trial Phase Trials
Completed 21
Not yet recruiting 4
Unknown status 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Rosuvastatin Calcium

Sponsor Name

Sponsor Name for Rosuvastatin Calcium
Sponsor Trials
AstraZeneca 10
Abbott 3
Torrent Pharmaceuticals Limited 2
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Rosuvastatin Calcium
Sponsor Trials
Industry 24
Other 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Baxter
Medtronic
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.